FEB 10, 2020 6:24 PM PST

Drug Prevents Coronavirus in Monkeys

WRITTEN BY: Nouran Amin

An antiviral drug successfully prevented Middle East respiratory syndrome coronavirus (MERS-CoV) in infected rhesus macaques. The drug, Remdesivir, was administered in the macaques before infection and improved their condition after infection. These findings are according to a new report from the NIH's National Institute of Allergy and Infectious Diseases (NIAID) and is published in the Proceedings of the National Academy of Sciences.

Learn more about the coronavirus:

MERS-CoV is similar to the 2019 novel coronavirus (SARS-CoV-2) that first emerged as a public health crisis in Wuhan, China. Previous studies observed the protection of animals against a variety of viral infections due to Remdesivir administration. Now, it was shown to experimentally treat monkeys with Ebola and Nipah viruses.

The present study investigated animals for six days that were 1) treated with remdesivir 24 hours before infection with MERS-CoV 2) those treated 12 hours after infection and 3) untreated control animals that showed signs of respiratory disease. The pre-infection animals had no signs of respiratory disease and no lung damage along with low levels of virus replication in the lungs in comparison to the control animals. For animals treated after infection, symptoms of the disease were less severe than in control animals.

The promising findings of the study encourage researches to push for clinical trials of remdesivir for MERS-CoV and COVID-19, the disease that SARS-CoV-2 causes. In fact, several studies for clinical trials of remdesivir for COVID-19 are under way in China, and other patients with COVID-19 have received the drug under a compassionate use protocol.

Source: Science Daily

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAR 03, 2022
Drug Discovery & Development
Blood Pressure Drug Increases Natural Insulin Production in Type 1 Diabetes
MAR 03, 2022
Blood Pressure Drug Increases Natural Insulin Production in Type 1 Diabetes
Individuals with type 1 diabetes who take blood pressure medication verapamil require less insulin on a daily basis. The ...
MAR 17, 2022
Drug Discovery & Development
CRISPR Vaccine Shows Promise in Preventing Disfiguring Skin Disease
MAR 17, 2022
CRISPR Vaccine Shows Promise in Preventing Disfiguring Skin Disease
Researchers at the Ohio State University College of Medicine have created a vaccine using CRISPR technology targeting Le ...
MAR 22, 2022
Drug Discovery & Development
A Guide on How to Prolong The Duration of Action of Inhaled Drugs
MAR 22, 2022
A Guide on How to Prolong The Duration of Action of Inhaled Drugs
Inhaling drugs is an ancient practice, with some researchers arguing the practice dates back as far as 3,000 BCE. W ...
MAR 29, 2022
Drug Discovery & Development
Keto Diet Boosts Chemotherapy for Pancreatic Cancer
MAR 29, 2022
Keto Diet Boosts Chemotherapy for Pancreatic Cancer
A ketogenic diet- or a ‘keto’ diet- which is high in fat and low in protein and carbohydrates, may help kill ...
APR 08, 2022
Immunology
How Zinc Can Boost the Function of the Immune System
APR 08, 2022
How Zinc Can Boost the Function of the Immune System
Zinc is a mineral that's known to boost the function of the immune system, and now scientists have learned more about ho ...
APR 21, 2022
Drug Discovery & Development
No Link Between Antidepressants and Improved Quality of Life
APR 21, 2022
No Link Between Antidepressants and Improved Quality of Life
Those who use antidepressant medications have a similar health-related quality of life to people who are depressed and w ...
Loading Comments...